Search
![](https://static.wixstatic.com/media/nsplsh_162feff45f5749d397c5464fa6ddcb22~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_162feff45f5749d397c5464fa6ddcb22~mv2.jpg)
![ICH/ USFDA Guidance: S12 Nonclinical Biodistribution Considerations for Gene Therapy Products](https://static.wixstatic.com/media/nsplsh_162feff45f5749d397c5464fa6ddcb22~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_162feff45f5749d397c5464fa6ddcb22~mv2.jpg)
Sharan Murugan
- Apr 29, 2023
- 2 min
ICH/ USFDA Guidance: S12 Nonclinical Biodistribution Considerations for Gene Therapy Products
On 27th April, 2023 the United States Food & Drug Administration Center for Drug Evaluation and Research, and Center for Biologics...
20 views0 comments